Evidence map›Paper›PMID 37631870›Full record

ReviewVaccines2023

Weile Xie, Longlong Wang, Dan Luo, Vijay Soni, Eric H Rosenn, Zhe Wang

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Construction of RecombinantPathogens (Basel, Switzerland) · 2026
    Article
  2. RecombinantHuman vaccines & immunotherapeutics · 2025
    Article
  3. Construction of aACS omega · 2025
    Article
  4. EngineeredJournal for immunotherapy of cancer · 2025
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Weile XieShanghai Key Laboratory of Veterinary Biotechnology, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai 200240, China.
Longlong WangShanghai Key Laboratory of Veterinary Biotechnology, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai 200240, China.
Dan LuoShanghai Key Laboratory of Veterinary Biotechnology, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai 200240, China.
Vijay SoniDivision of Infectious Diseases, Weill Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.ORCID 0000-0002-3395-7429
Eric H RosennSchool of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.ORCID 0009-0000-6084-8933
Zhe WangShanghai Key Laboratory of Veterinary Biotechnology, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai 200240, China.
Shanghai Jiao Tong University · CNCornell University · USTel Aviv University · IL

Funding

National Key Research and Development Plans of China 2021YFD1800401National Natural Science Foundation of China 32070128Shanghai Biomedical Science and Technology Support Special Project 21S11900200
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

infectious diseasesM.smomicssystem biologytuberculosisvaccine vectorvaccinomics

Identifiers

PMID37631870
PMCPMC10459588
OpenAlexW4385416219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.